Head & Neck Cancer + Colorectal Cancer

Within your health trust how many patients are currently [within the past 6 months] being treated for head and neck cancer (Squamous cell carcinoma)?  111

Of these patients how many are locally advanced and how many are recurrent and/or metastatic head and neck cancer patients? 

A. Locally advanced – 98 new primary cancers treated
B. Recurrent and/or metastatic – 13 patients 

Of the these patients please split by their current drug treatment;
Carboplatin (Only or in combination with 5-FU)
Cetuximab (Erbitux) and chemotherapy or radiotherapy
Cetuximab (Erbitux) Only
Cisplatin (Only or in combination with 5-FU)
Docetaxel (Taxotere), (Only or in combination with 5-FU)
Fluorouracil (5FU)
Radiotherapy Only
Other – Specify

The Royal Surrey County Hospital NHS Foundation Trust does have dispensing records for these agents but we do not record the indication for which the agent is to be used for at the point of dispensing.

These agents are not solely used in head and neck cancers or colorectal cancers therefore this information is not available centrally and the cost of compliance to gather, analyse and report on the requested information would exceed the appropriate limit under Section 12 of the Freedom of Information Act.

Does your health trust participate in any ongoing clinical trials for the treatment of head and neck cancer patients, if so please could you provide details?  The Royal Surrey County Hospital NHS Foundation Trust does participate in head and neck cancer patient clinical trials, below table listing the ongoing trials:

Local project reference Project Title Project site Start date (NHS Permission) Study Type Project site status
11ONCN0012 DORIC – Phase II trial of cediranib +/- gefitinib for recurrent glioblastoma 21/06/2011 IMP Closed
12ONCN0003 De-ESCALaTE HPV 13/03/2012 IMP Open
NCOM0113 ‘HiLo’ 06/01/2007 IMP Closed to recruitment – in follow up
13ONCN0016 Hydroxychloroquine Trial (HCQ) 17/10/2013 IMP Open
14ONCN0007 NIMRAD (NIMorazole/placebo plus RADiotherapy in head and neck cancer) 06/03/2015 IMP Open

Within your health trust how many patients are currently [within the past 6 months] being treated for metastatic Colorectal Cancer? 86 patients

Of those patients please split by their current drug treatment;

Bevacizumab
Cetuximab
Panitumumab
Aflibercept
Oxaliplatin
Irinotecan
5-Fluorouracil
Irinotecan with 5-fluorouracil (5FU) and folinic acid [FOLFIRI]
Oxaliplatin with 5-fluorouracil (5FU) and folinic acid [FOLFOX]
Capecitabine and oxalipatin (CAPOX / XELOX)
Capecitabine and irinitecan (CAPIRI)
Other – Specify

The Royal Surrey County Hospital NHS Foundation Trust does have dispensing records for these agents but we do not record the indication for which the agent is to be used for at the point of dispensing.

These agents are not solely used in head and neck cancers or colorectal cancers therefore this information is not available centrally and the cost of compliance to gather, analyse and report on the requested information would exceed the appropriate limit under Section 12 of the Freedom of Information Act.

©2017 Royal Surrey County Hospital

Log in with your credentials

or    

Forgot your details?